A clinical study of Mavilingapattai Kudineer in the management of Thandagavatham (Lumbar Spondylosis)

A prospective open labelled non randomized phase II clinical trial of Mavilingapattai Kudineer in the management of Thandagavatham (Lumbar Spondylosis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031215

Enrollment

Registered

2021-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Mavilingapattai Kudineer: 30ml orally twice a day after food for 45 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with pain and stiffness in the lumbar region, radiating pain to buttocks and lower limbs, pain aggravating on forward and backward bending. Patient with positive Schober and Straight Leg Raising test. Patient complaining of back pain functional scale score should be range from below 30.

Exclusion criteria

Exclusion criteria: Age below 30 and above 60 years. Tuberculosis of spine. Systemic Lupus Erythematosus Chronic Kidney Disease Fracture of spine Congenital Spino vertebral deformities Mixed connective disease Pregnancy Lactating mother Chronic Liver Disease

Design outcomes

Primary

Measure	Time frame
Reduction of the symptoms of the pain in lumbar and lower limbs. Improvement of the range of movements in the Lumbar and lower limbs.Timepoint: 45 days	—

Secondary

Measure	Time frame
Evaluation of additional effects and siddha parameters changes in ThandagavathamTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr S Justus Antony MDs

Government Siddha Medical College and Hospital

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026